• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

3D MR brings new insight into bipolar disorders

Article

Three-D MR is lending new muscle to the theory that lithium rebuilds or repairs gray matter in specific regions of the brain in patients with bipolar disorders.

Three-D MR is lending new muscle to the theory that lithium rebuilds or repairs gray matter in specific regions of the brain in patients with bipolar disorders.

Principal investigator Carrie Bearden, Ph.D., and colleagues at the University of California, Los Angeles enrolled 28 adult patients with bipolar disorder, most of whom were being treated with lithium, and 28 healthy subjects. The investigators used 3D structural brain mapping to analyze gray matter spots at multiple cortical locations. They found a statistically significant difference in gray matter density between bipolar patients and control subjects in the brain regions that control attention, motivation, and emotion. The technique will help develop new treatments that match lithium's effectiveness but without its toxic effects, Bearden said.

Investigators published results in the July issue of Biological Psychiatry.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.